Filter your results
- 2
- 1
- 3
- 3
- 1
- 2
- 3
- 3
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 3
- 2
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
|
|
sorted by
|
|
Targets for MAbs: innovative approaches for their discovery & validation, LabEx MAbImprove 6 th antibody industrial symposium, June 25-26, 2018, Montpellier, FrancemAbs, 2019, 11 (5), pp.812-825. ⟨10.1080/19420862.2019.1612691⟩
Journal articles
hal-02448613v1
|
||
|
Immunotherapy of triple-negative breast cancer with cathepsin D-targeting antibodiesJournal for Immunotherapy of Cancer, 2019, 7 (1), pp.29-46. ⟨10.1186/s40425-019-0498-z⟩
Journal articles
hal-02335397v1
|
||
|
Host succinate inhibits influenza virus infection through succinylation and nuclear retention of the viral nucleoproteinEMBO Journal, 2022, 41 (12), pp.e108306. ⟨10.15252/embj.2021108306⟩
Journal articles
hal-03687124v2
|